Publications by authors named "P W Mathieson"

The opening line of a recent article put it best: "Relations between the UK and EU badly need a reset." Although the article was mostly about geopolitics, the disconnect also applies to science and the current uncertainty about whether the UK will remain an associated partner in European Union (EU) research programs such as Horizon Europe. In the post-Brexit era, and with a new UK Prime Minister to be named shortly, the UK and EU should be considering how best to maximize the potential of the numerous brilliant scientists, technicians, academics, and clinicians working in the universities and research institutes of all European countries, including the UK.

View Article and Find Full Text PDF

Introduction: Shiga toxin 2a (Stx2a) induces hemolytic uremic syndrome (STEC HUS) by targeting glomerular endothelial cells (GEC).

Objectives: We investigated in a metabolomic analysis the response of a conditionally immortalized, stable glomerular endothelial cell line (ciGEnC) to Stx2a stimulation as a cell culture model for STEC HUS.

Methods: CiGEnC were treated with tumor necrosis factor-(TNF)α, Stx2a or sequentially with TNFα and Stx2a.

View Article and Find Full Text PDF

Albuminuria affects millions of people, and is an independent risk factor for kidney failure, cardiovascular morbidity and death. The key cell that prevents albuminuria is the terminally differentiated glomerular podocyte. Here we report the evolutionary importance of the enzyme Glycogen Synthase Kinase 3 (GSK3) for maintaining podocyte function in mice and the equivalent nephrocyte cell in Drosophila.

View Article and Find Full Text PDF

Atypical hemolytic uremic syndrome (aHUS) is a severe disease characterized by microvascular endothelial cell (EC) lesions leading to thrombi formation, mechanical hemolysis and organ failure, predominantly renal. Complement system overactivation is a hallmark of aHUS. To investigate this selective susceptibility of the microvascular renal endothelium to complement attack and thrombotic microangiopathic lesions, we compared complement and cyto-protection markers on EC, from different vascular beds, in and models as well as in patients.

View Article and Find Full Text PDF
Article Synopsis
  • Elevated VEGF A levels contribute to glomerular endothelial cell dysfunction and albuminuria in diabetic nephropathy, suggesting a need for protective strategies.
  • The study tested VEGFC as a counteractive agent to VEGFA, finding that it significantly reduced albumin permeability and preserved glomerular function in experimental settings.
  • Results indicate that VEGFC may offer a promising therapeutic pathway by reducing diabetic nephropathy progression and maintaining endothelial barrier integrity.
View Article and Find Full Text PDF